Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
Clinical trial NCT00979251 · COMPLETED
Trial details
- NCT number
- NCT00979251
- Sponsor
- Adamas Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.